Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms

Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms

Background Patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) are at an increased risk for infection related to the use of immunomodulatory therapies (ITs). The objective of this study is to assess the impact of ITs on the adaptive immune responses to SARS-CoV-2.Methods The study po...

Full description

Saved in:
Bibliographic Details
Main Authors: Francis Berenbaum, Bruno Fautrel, Jérémie Sellam, Corinne Miceli-Richard, Clementina López-Medina, Jacques Morel, Jerome Avouac, Hélène Péré, Hugo Mouquet, Béatrice Parfait, Thomas Bruneau, Sylvie Van Der Werf, Olivier Fogel, Maxime Beretta, Emmanuel Martin, Cyril Planchais, Pedro Goncalves, James P Di Santo, Sylvie Behillil, Sylvain Latour
Format: Article
Language:English
Published: BMJ Publishing Group 2025-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/3/e005673.full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://rmdopen.bmj.com/content/11/3/e005673.full

Similar Items